David AdamsJonas WixnerMichael PolydefkisJohn L. BerkIsabel M. ConceiçãoAngela DispenzieriAmanda PeltierMitsuharu UedaShaun BenderKelley CapocelliPatrick Y. JayElena YurenevaLaura ObiciGiuseppe VitaVincenzo RizzoMassimo RussoAnna MazzeoLuca GentileJohn L BerkJanice WiesmanMichelle KakuVincent LauDouglas DeLongJames DaltonJohn MayShahram AttarianEmilien DelmontJean PougetAnnie VerschuerenAude-Marie GrapperonEmmanuelle Campana-SalortIsabel M ConceiçãoCarlos NevesMiguel O SantosConceição de Azevedo CoutinhoCatarina Falcao de CamposTeresa CoelhoAntonio H ReisNuno CorreiaJavier M PerezAna Martins da SilvaCristina AlvesMarcio CardosoKatia ValdrezJulia R MonteMarta NovaisNadia GuimaraesInes CardosoMonica FreitasJoana RamalhoNatalia FerreiraDaisuke KuzumeMasahiro YamasakiYuko MorimotoCeline TardEric HachullaClement GauvainMaria-Claire Migaud-ChervyDominique DeplanqueElsa JozefowiczLoic LebellecDavid AdamsMarie Théaudin-SaliouCécile Cauquil-MichonCeline LabeyrieAdeline NotAbdallah Al-SalamehAnne-Lise LecoqMaeva StephantAndoni Echaniz-LagunaLaurent BecquemontGuillemette BeaudonnetVincent AlgalarrondoLudivine EliahouMichel S SlamaAntoine RousseauAissatou SignatePaola DarcheJerome GrimaudEmeline BerthelotJocelyn InamoViolaine Planté-BordeneuveThierry GendreRaphaele ArrouasseSamar S AyacheLaura ErnandePhilippe Le CorvoisierHayet SalhiAriane ChoumertCyril CharlinThomas MegelinThomas H Brannagan IIISteven TsangFernanda WajnsztajnJeffrey ShijeChristina UlaneInna KleymanLouis WeimerComana CioroiuKleopas KleopaEleni Zamba-PapanicolaouSatoshi TadaMasahiro NagaiRina AndoYuki YamanishiJ Scott OvercashSinikka GreenMichael WatersDerya J CoskunPaul ManosKarla A ZepedaWilliam O’RiordanLaura ObiciAndrea CorteseAlessandro LozzaGiampaolo MerliniVittorio RostiMario SabatelliGiulia BisogniDaniela BernardoMarco LuigettiAndrea Di PaolantonioValeria GuglielminoAngela RomanoHans NienhuisArnt V KristenChristian NagelFabian aus dem SiepenSelina HeinShuichiro NeshigeJosep M CampistolLida Maria Rodas MarinJosep Miquel Blasco PelicanoLucía Galán DávilaVanesa Pytel CordobaAntonio Guerrero SolaAlejandro HorgaJulián García FeijooLeopoldo Perez de IslaWilson Marques JúniorCarolina Lavigne MoreiraVanessa Daccach MarquesFrancisco Munoz BeamudCristina BorracheroInés AL LópezMonica SanzElena Rigo OliverJuan González MorenoJose M Gamez MartinezCristina DescalsMercedes UsonFrancisco Jose VegaAntoni FiguerolaCarles MontalaMárcia Waddington-CruzAline Souza de AbreuMoises Dias da SilvaRenata Gervais de Santa RosaMarcus Vinicius PintoAmanda Cardoso BerensztejnLuiz Felipe PintoMariana de Andrade GuedesFabio BarrosoAndrea LautreLucas G OrellanaMaria Alejandra González-Duarte BriseñoKarla Cárdenas-SotoCarlos Gerardo Cantú BritoDavid Rivera de la ParraJose Pablo Hernandez ReyesMaria del Mar Saniger AlbaYesim ParmanErdi SahinNail G SerbestHacer DurmusArman CakarSacit KaramurselAli ElitokNermin G Sirin InanEmre AltinkurtMichael PolydefkisAdriane C AllenVinay ChaudhryRaquel JarrettNeil BresslerMandeep SinghMohammad KhoshnoodiDaniel P JudgeAlvin T LuiTae Hwan ChungGeno VistaSyed Mahmood ShahHirotoshi HamaguchiTetsuya OdaMasahiro ShimomuraChristof ScheidUdo HoltickJeeyoung OhHee Jin KimHyun Jin ShinKyomin ChoiMitsuharu UedaYohei MisumiToshiya NomuraTakahisa TateishiElizabeth A MauricioElliot DimbergLeslie T CooperAngela DispenzieriAmie FonderMiriam HobbsPeter DyckWilson GonsalvesNelson LeungThomas E WitzigLisa HwaPrashant KapoorShaji K KumarYi LinVincent S RajkumarDavid DingliMorie A GertzPeter J DyckLinde GoveSamir DaliaDavid CroyTim HoldingPeter GorevicCHI-CHAO CHAOMING-JEN LEESenda Ajroud-DrissSUNG-TSANG HSIEHRobert SufitLI-KAI TSAICHIH-CHAO YANGJEN-JEN SUCHAO-WEN LINSHIN-JOE YEHJohn-Michael LiMiriam FreimerSamantha LoRussoYasuhiro AsoByoung-Joon KimJuHyeon KimGa Yeon LeeEun Bin ChoEun-Seok JeonJu-Hong MinJin Myoung SeokHye Lim LeeJae Hong ParkYoshiki SekijimaNagaaki KatoDai KishidaAkiyo HinenoMinori KodairaTsuneaki YoshinagaKen TakasoneTeruyoshi MiyaharaYusuke TakahashiAkira ImaiKazuhiko MatsumotoKon-Ping LinYi-Chung LeeJonas WixnerBjorn PilebroOle SuhrIntissar AnanErik NordhFatima Pedrosa-DomellöfMaria ChermeninaAnneli NygrenIvaylo TournevSashka Zhelyazkova-GlaveevaZheyna ChernevaStaiko SarafovTeodora ChamovaSylvia Cherninkova-GopinaHartmut H SchmidtElena VoronaAnna Huesing-KabarMatthias SchillingIyad KabarPhil-Robin TepasseJulian D GillmoreAna Martinez-NaharroLiza ChackoOliver CohenSteven LawTamer RezkHelen J LachmannDianna QuanStacy DixonVera FridmanSoon Chai LowKhean Jin GohMichelle M MezeiKristin JackN. Kevin WadeGlenn LopateStephanie GeislerR. Brian SommervilleJulaine FlorenceGraeme StewartMark TaylorDaniel Suan2025-05-062025-05-062025-03-10https://scholars.lib.ntu.edu.tw/handle/123456789/728932Importance There is a lack of long-term efficacy and safety data on hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN) and on RNA interference (RNAi) therapeutics in general. This study presents the longest-term data to date on patisiran for hATTR-PN. Objective To present the long-term efficacy and safety of patisiran in adults with hATTR-PN. Design, Setting, and Participants This global open-label extension (OLE) of the APOLLO randomized clinical trial and phase 2 OLE study enrolled patients from 43 hospitals or clinical centers across 19 countries between July 2015 and August 2017, with follow-up until November 2022. Of 212 eligible patients with hATTR who completed the phase 3 APOLLO or phase 2 OLE parent studies, 211 enrolled in and 138 completed the global OLE. Intervention Patisiran, 0.3 mg/kg, intravenously once every 3 weeks for up to 5 years. Main Outcomes and Measures Outcomes evaluated at year 5 of the global OLE included disability (polyneuropathy disability [PND] score); polyneuropathy severity (Neuropathy Impairment Score [NIS]), nutritional status (modified body mass index [mBMI]), quality of life (Norfolk Quality of Life–Diabetic Neuropathy [Norfolk QOL-DN]), and Rasch-Built Overall Disability Scale (R-ODS), with no statistical hierarchy. Safety, survival probability, and mortality were also assessed. Results At the global OLE baseline, the mean (SD) age was 61.3 (12.3) years, and 156 patients (73.9%) were male. In 138 patients completing the study, PND scores remained stable or improved in 89 patients (65.0%), NISs showed a mean (SD) change of 10.9 (14.7), and mean (SD) mBMI (calculated as weight in kilograms divided by height in meters squared times serum albumin in grams per liter) increased by 46.4 (120.7) over 5 years from baseline. Norfolk QOL-DN and R-ODS scores showed mean (SD) changes of 4.1 (16.7) and –3.7 (6.2), respectively. Adverse events (AEs) leading to study withdrawal occurred in 47 patients (22.3%). Infusion-related reactions were the most common treatment-related AE (n = 34 [16.1%]). Overall, 41 patients (19.4%) died during the study. Patisiran treatment in the parent study and low familial amyloid polyneuropathy score at parent study baseline were associated with significantly improved survival. Conclusions and Relevance In the longest study of an RNAi therapeutic for any disease, patisiran treatment resulted in modest changes for patients with hATTR-PN with an acceptable safety profile. These results highlight the importance of initiating early treatment for hATTR and the potential of RNAi therapeutics in medicine. Trial Registration ClinicalTrials.gov Identifier: NCT02510261[SDGs]SDG2journal article10.1001/jamaneurol.2024.463139804640